Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-28

Clinical Trial Update: A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours [Phase 1]

View source ↗

Summary

Phase 1 study of varlitinib in Japanese patients with advanced or metastatic solid tumors, including biliary tract cancer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varlitinib (varlitinib)

Snippet

Sponsor: ASLAN Pharmaceuticals | Conditions: Advanced or Metastatic Biliary Tract Cancer, Advanced or Metastatic Solid Tumors | Phase 1 | Status: COMPLETED